Vinmec pioneers in applying gene testing technology to screen for type 2 diabetes risk

The gene test for early screening for diabetes risk (diabetes mellitus) is a cooperation product between Vinmec Health System and DNA Link - one of the leading companies in research and development of biomedical technology and biomedical technology. Gene analysis in Korea. The test was first applied at Vinmec, helping to screen the risk of type 2 diabetes and is recommended for people with pre-diabetes or patients who already have diabetes to have the most effective treatment regimen.

Gene testing to assess the risk of type 2 diabetes is carried out based on modern, broadband genetic analysis technology, assessing the interaction of genetic variations on related genes. The analysis and assessment of the role of these genetic variations is based on the largest database of Asians (including Vietnamese), in order to help give the most accurate results for Vietnamese.

Pre-diabetes gene test will help predict and screen the risk of type 2 diabetes in the group of pre-diabetic people or people with abnormal signs of blood sugar index and healthy people who want to be screened. early control. In addition, the test also helps assess the risk of abnormalities with other important body health indicators such as body mass index (BMI), blood lipids, risk index for hypertension, resistance. insulin... Because the age of diabetes is getting younger and younger, customers of all ages who suspect or want to be screened early can perform this test even if there are no clinical signs of diabetes. sick. This test is also especially important for people who already have type 2 diabetes. The test results will help the doctor determine the exact cause and recommend the most appropriate treatment plan.

To perform the prediabetes gene test, the tester only needs to take blood like other normal blood tests or collect a sample of the oral mucosa (no pain). Sampling time is only 3-5 minutes, the results will be notified to customers by Vinmec International General Hospital after 2 weeks.
In case the customer is determined to have genetic factors that increase the risk of type 2 diabetes, Vinmec doctors and genetics experts will advise on nutrition and physical activity, as well as the main examination schedule. Helping customers have healthy lives in the future.
If a customer has a high-risk gene carrier result and requires early treatment intervention, Vinmec will connect with other clinical specialties, providing an optimal treatment, management and care plan to improve treatment. effectiveness of treatment and minimize the risk of possible complications.
In particular, this is a test that only needs to be performed once. Physicians can combine the results of this genetic test with clinical information at many other visit points throughout a client's life to optimize for personalized and tailored treatment. .

Currently, type 2 diabetes is increasing in Vietnam and around the world with many serious complications such as blindness, kidney failure, amputation, cerebrovascular accident, myocardial infarction .. However, according to statistics of the Ministry of Health, up to 70% of patients have not been diagnosed correctly. The disease often progresses silently, without symptoms, so it is difficult to detect early. If screened early through periodic health checks and most recently through genetic testing, patients can promptly adjust their nutrition and change their lifestyle.
Gene testing to detect diabetes risk along with more than 70 types of cancer, chronic diseases, drug allergies and personal characteristics are gene products approved by Vinmec Center for Comprehensive Health Care for Healthy People. (Wellness Center) launched in March 2021. This is an area of ​​strength that Vinmec focuses on, in order to help people access advanced screening technologies in the world in the field of healthcare in Vietnam.